Compare Five9 Inc (FIVN) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five9 Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Five9 Inc trades at $33.37 (market cap $2.65B), while GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 11.7× Five9 Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Five9 Inc pays none. Which is the better fit depends on your goals.
| FIVN | GEHC | |
|---|---|---|
Market Cap | $2.65B | $31.07B |
Volume | 971,747 | 3,443,020 |
Sector | Technology | Health |
52-Week High | $38.65 | $88.16 |
52-Week Low | $13.61 | $59.48 |
Typical Hold Time | 72 Days | — |
Enterprise Value | $2.80B | $39.53B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five9 (FIVN) trades at $33.08, down 7.26% today amid recent volatility, though the stock remains near its 52-week high of $39.55. The company shows strong fundamental momentum with three consecutive quarterly earnings beats and accelerating AI revenue growth reaching 78% year-over-year. Technical indicators suggest a bullish trend with moving averages supporting upside potential, while RSI levels remain neutral. Five9 maintains leadership in the contact center-as-a-service market with improving profitability margins.
The outlook remains positive with analyst consensus favoring Buy ratings (61%) and a $34 price target representing 3% upside. Key opportunities include AI revenue expansion and market leadership, while risks involve insider selling activity and competitive pressures in the CCaaS space. The company's transition to profitability and strong subscription growth support continued investor interest.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
